Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People on Optimized ART With Undetectable Plasma HIV RNA
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2017
At a glance
- Drugs ALT 803 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Proof of concept
- 07 Jun 2017 Biomarkers information updated
- 19 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 19 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.